The protective efficacy of Bharat Biotech's Covaxin following two and three-dose immuniszations against the Delta variant and the efficacy ...

Days after Delhi government made precaution/booster doses available free of cost for those between 18 and 59 years of age in government hos...

Pfizer has asked the US Drug regulators to allow a second Covid-19 booster dose for people aged 65 and above, citing data from Israel's stu...

The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation had on Friday recommended giving permission for...

The official said additional need for vaccination and inclusion of population for vaccination is examined constantly.

For the evening with friend, the actor was filmed playing his guitar.

From January 10 healthcare workers, front line workers and persons aged 60 years and above with co-morbid conditions will be eligible for t...

The Union Health Ministry on Tuesday said that all those who are above 60 years of age with co-morbidities do not need to provide any docto...

"The central government has accepted my suggestion for a booster dose -- this is a right step. The protection of vaccines and booster shots...

"Need volunteers for a clinical trial. People who have been administered two doses of Covaxin three to six months ago are eligible to enrol...

The Health Ministry told the Lok Sabha last week that the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) and the Nat...

Many have begun taking the boosters as they feel insecure about their diminishing immunity and antibodies, said Naresh Trehan, chairman of ...

Protection against COVID-19 infection wanes over time, which has driven consideration of boosters to protect the most vulnerable and lessen...

In an application to the Drugs Controller General of India (DCGI), Prakash Kumar Singh, the Director, Government and Regulatory Affairs at ...

"The National Technical Advisory Group on Immunization (NTAGI) and National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) ar...

"India will decide on booster dose based on scientific evidence generated locally. Studies are already underway to determine the need and t...

The company is studying administration of a booster dose in a separate Phase-2 trial. It has approached the Subject Expert Committee (SEC) ...